Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.

about

Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.

P2860

Q55341968-858F154E-FB1F-45F1-A148-19F3C2F04F48

P2860

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q36099620

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@ast

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@en

type

Item

label

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@ast

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@en

prefLabel

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@ast

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@en

P1476

Drug retention and safety of T ...... nts with rheumatoid arthritis.

@en

P2093

Chan-Bum Choi

http://www.w3.org/2001/XMLSchema#string

Dae-Hyun Yoo

http://www.w3.org/2001/XMLSchema#string

Dam Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Bum Jun

http://www.w3.org/2001/XMLSchema#string

Soo-Kyung Cho

http://www.w3.org/2001/XMLSchema#string

Soyoung Won

http://www.w3.org/2001/XMLSchema#string

Tae-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Yoon-Kyoung Sung

http://www.w3.org/2001/XMLSchema#string

P2860

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.

TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany.

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.

The influence of ageing on the development and management of rheumatoid arthritis.

P2888

s12891-016-1185-6

P304

333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12891-016-1185-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Cheol Bae

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045571462

http://www.w3.org/2001/XMLSchema#string

P698

27507033

http://www.w3.org/2001/XMLSchema#string

P932

4977640

http://www.w3.org/2001/XMLSchema#string

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.

about

P2860

P2860

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932